Publication

Hepatoprotective effects of the long-acting FGF21 analogue PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

American Journal of Physiology – Gastroenterology and Liver Physiology 324(5):G378-G388, 2023 Nielsen MH, Gillum MP, Vrang N, Jelsing J, Hansen HH, Feigh M, Oró D

 

 

Share this page

Resource Library

Related resources
Publication
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
Open
Publication
Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis
Open
Poster
A3907, a novel inhibitor of bile acid transport in the intestine and the kidney, improves markers of metabolic and hepatic pathology and reduces NAFLD activity score and fibrosis stage in a diet-induced and biopsy-confirmed mouse model of nonalcoholic steatohepatitis
Open
Publication
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
Open

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top